In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...

Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Loyal has a trio of longevity drugs in the works, including two meant to specifically target larger breeds that typically ...